A mixed performance in the stock price over the year has left investors unsure of what to expect, resulting in a range of outlooks from optimistic to pessimistic. The index has shown a price loss of -24.67% this year. Over the last six months, there has been a stronger performance of -8.13%. The price of IMUX leaped by -1.74% during the last 30 days period. For the last 5-days stocks have slided -7.38%.
Immunic Inc ‘s stock market performance has been somewhat erratic. The company’s stock reached a 1-year high price of $2.11 on 09/19/24, while the lowest value for the same period was recorded at $0.97 on 06/26/24.
52-week price history of IMUX Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Immunic Inc’s current trading price is -46.45% away from its 52-week high, while its distance from the 52-week low is 16.49%. The stock’s price range during this period has varied between$0.97 and $2.11. The Immunic Inc’s shares, which operate in the Healthcare, saw a trading volume of around 0.82 million for the day, a figure considerably lower than their average daily volume of 0.9 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Immunic Inc (IMUX) has experienced a quarterly decline of -25.66% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 101.79M and boasts a workforce of 77 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.3821, with a change in price of -0.3300. Similarly, Immunic Inc recorded 675,723 in trading volume during the last 100 days, posting a change of -22.60%.
IMUX’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for IMUX stands at 0.02. Similarly, the long-term debt-to-equity ratio is also 0.00.
IMUX Stock Stochastic Average
As of today, Immunic Inc’s raw stochastic average for the last 50 days stands at 15.49%. This is a decline compared to the raw stochastic average of the previous 20 days, which was noted at 27.50%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 43.33% and 55.83%, respectively.
